Pharmacotherapy for Cardiac Amyloidosis
Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)06/14/23 • 29 min
In this podcast, experts will discuss the latest pharmacologic recommendations and their evolution in the treatment of cardiac amyloidosis. They will delineate the different potential therapeutic targets for the pharmacotherapy of cardiac amyloidosis including TTR silencing, stabilization, and disruption.
Claim CE and MOC at https://bit.ly/ATTR-CM_series
06/14/23 • 29 min
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/closing-knowledge-gaps-in-transthyretin-cardiomyopathy-attr-cm-543979/pharmacotherapy-for-cardiac-amyloidosis-69989667"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to pharmacotherapy for cardiac amyloidosis on goodpods" style="width: 225px" /> </a>
Copy